Chromosomal characterization of cryopreserved mesenchymal stem cells from the human subendothelium umbilical cord vein

Regenerative Medicine

Volumn 7, Issue 2, 2012, Pages 147-157

  Duarte, Denise M ^a   Cornélio, Déborah A ^a   Corado, Carolina ^a,b   Medeiros, Viviane K S ^a,c   Da Costa Xavier De Araújo, Luíza A ^a   Cavalvanti, Geraldo B ^a   De Medeiros, Silvia R B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b Centro Federal de Educacao Tecnologica do Rio Grande do Norte   (Brazil)

^c UNIVERSIDADE FEDERAL DO VALE DO SÃO FRANCISCO   (Brazil)

Author keywords

biosafety; cryopreservation; cytogenetic analysis; human mesenchymal stem cell; nonclonal chromosome aberration

Indexed keywords

5' NUCLEOTIDASE; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; ENDOGLIN; MEMBRANE ANTIGEN; THY 1 ANTIGEN;

ARTICLE; BIOSAFETY; CELL ASSAY; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL POPULATION; CELL STRUCTURE; CELL VIABILITY; CHONDROGENESIS; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPING; MESENCHYMAL STEM CELL; MONOSOMY; OSTEOBLAST; PARACENTRIC CHROMOSOME INVERSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL EXPANSION; SUBENDOTHELIUM; UMBILICAL VEIN;

ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SEPARATION; CELL SHAPE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN; CRYOPRESERVATION; ENDOTHELIUM; FEMALE; FLOW CYTOMETRY; HUMANS; KARYOTYPING; MESENCHYMAL STEM CELLS; UMBILICAL CORD; UMBILICAL VEINS;

EID: 84858194579     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.113     Document Type: Article

References (55)

1. Meirelles L da S, Nardi NB. Methodology, biology and clinical applications of mesenchymal stem cells. Front. Biosci. 14, 4281-4298 (2009).
2. Singer NG, Caplan AI. Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 28(6), 457-478 (2011).
3. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
4. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell Physiol. 213(2), 341-347 (2007). (Pubitemid 47509711)
5. Lindner U, Kramer J, Rohwedel J, Schlenke P. Mesenchymal stem or stromal cells: toward a better understanding of their biology? Transfus. Med. Hemother. 37(2), 75-83 (2010).
6. Wang L, Ott L, Seshareddy K, Weiss ML, Detamore MS. Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells. Regen. Med. 6(1), 95-109 (2011).
7. Kadivar M, Khatami S, Mortazavi Y, Shokrgozar MA, Taghikhani M, Soleimani M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 340, 639-647 (2006). (Pubitemid 43021794)
8. Li M, Zhang SZ, Guo YW et al. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinsons disease. Neurochem. Res. 35(10), 1522-1529 (2010).
9. Ishige I, Nagamura-Inoue T, Honda MJ et al. Comparison of mesenchymal stem cells derived from arterial, venous, and Whartons jelly explants of human umbilical cord. Int. J. Hematol. 90(2), 261-269 (2009).
10. Caisander G, Park H, Frej K et al. Chromosomal integrity maintained in five human embryonic stem cell lines after prolonged in vitro culture. Chromosome Res. 14, 131-137 (2006).
11. Bernardo ME, Zaffaroni N, Novara F et al. Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer 67, 9142-9149 (2007). (Pubitemid 47535900)
12. Poloni A, Maurizi G, Babini L et al. Human mesenchymal stem cells from chorionic villi and amniotic fluid are not susceptible to transformation after extensive in vitro expansion. Cell Transplant. 20(5), 643-654 (2010).
13. Fietz T, Berdel WE, Rieder H et al. Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone Marrow Transplant. 23, 1109-1115 (1999). (Pubitemid 29259666)
14. Cowan CA, Klimanskaya I, McMahon J et al. Derivation of embryonic stem-cell lines from human blastocysts. N. Engl. J. Med. 350, 1353-1356 (2004). (Pubitemid 38375373)
15. Draper JS, Smith K, Gokhale P et al. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nat. Biotechnol. 22, 53-54 (2004). (Pubitemid 38057956)
16. Kim JW, Kim SY, Park SY et al. Mesenchymal progenitor cells in the human umbilical cord. Ann. Hematol. 83, 733-738 (2004). (Pubitemid 39485542)
17. Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K. Genomic alterations in cultured human embryonic stem cells in defined conditions. Nat. Genet. 37, 1099-1103 (2005). (Pubitemid 41486662)
18. Seol HW, Oh SK, Park YB et al. Separation and maintenance of normal cells from human embryonic stem cells with trisomy 12 mosaicism. Chromosome Res. 16, 1075-1084 (2008).
19. Ueyama H, Horibe T, Hinotsu S et al. Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions. J. Cell. Mol. Med. doi:10.1111/j.1582-4934.2011.01303.x (2011) (Epub ahead of print).
20. Wang Y, Huso DL, Harrington J et al. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 7, 509-519 (2005). (Pubitemid 43078081)
21. Hunt CJ. Cryopreservation of human stem cells for clinical application: a review. Transfus. Med. Hemother. 38(2), 107-123 (2011).
22. Yalvaç ME, Ramazanoglu M, Tekguc M et al. Human tooth germ stem cells preserve neuro-protective effects after long-term cryo-preservation. Curr. Neurovasc. Res. 7(1), 49-58 (2010).
23. Wilson A, Butler PE, Seifalian AM. Adipose-derived stem cells for clinical applications: a review. Cell Prolif. 44, 86-98 (2011).
24. Rebelatto CK, Aguiar AM, Moretão MP et al. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp. Biol. Med. (Maywood) 233, 901-913 (2008).
25. Henegariu O, Heerema NA, Lowe Wright L, Bray-Ward P, Ward DC, Vance GH. Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing. Cytometry 43, 101-109 (2001).
26. ISCN 2009. An International System for Human Cytogenetic Nomenclature. Shaffer LG, Slovak ML, Campbell LJ (Eds). S Karger AG, Switzerland (2009).
27. Secco M, Zucconi E, Vieira NM et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem Cells 26, 146-150 (2008).
28. Gunetti M, Ferrero I, Rustichelli D et al. Refreezing of cord blood hematopoietic stem cells for allogenic transplantation: in vitro and in vivo validation of a clinical Phase I/II protocol in European and Italian Good Manufacturing Practice conditions. Exp. Hematol. 36, 235-243 (2008).
29. Can A, Karahuseyinoglu S. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 25, 2886-2895 (2007). (Pubitemid 350127873)
30. Liu G, Zhou H, Li Y et al. Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 57(1), 18-24 (2008).
31. Woods EJ, Perry BC, Hockema JJ, Larson L, Zhou D, Goebel WS. Optimized cryopreservation method for human dental pulp-derived stem cells and their tissues of origin for banking and clinical use. Cryobiology 59, 150-157 (2009).
32. Liu Y, Xu X, Ma X, Martin-Rendon E, Watt S, Cui Z. Cryopreservation of human bone marrow-derived mesenchymal stem cells with reduced dimethylsulfoxide and well-defined freezing solutions. Biotechnol. Prog. 26(6), 1635-1643 (2010).
33. Miura M, Miura Y, Padilla-Nash HM et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24, 1095-1103 (2006). (Pubitemid 44464742)
34. Bochkov NP, Nikitina VA, Buyanovskaya OA et al. Aneuploidy of stem cells isolated from human adipose tissue. Bull. Exp. Biol. Med. 146, 344-347 (2008).
35. Tolar J, Nauta AJ, Osborn MJ et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25, 371-379 (2007). (Pubitemid 46232791)
36. Meza-Zepeda LA, Noer A, Dahl JA, Micci F, Myklebost O, Collas P. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J. Cell. Mol. Med. 12, 553-563 (2008). (Pubitemid 351555134)
37. Buyanovskaya OA, Kuleshov NP, Nikitina VA, Voronina ES, Katosova LD, Bochkov NP. Spontaneous aneuploidy and clone formation in adipose tissue stem cells during different periods of culturing. Bull. Exp. Biol. Med. 148, 109-112 (2009).
38. Foudah D, Redaelli S, Donzelli E et al. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res. 17, 1025-1039 (2009).
39. Stacey GN, Auerbach JM. Quality control procedures for stem cell lines. In: Culture of Human Stem Cells. Freshney RI, Stacey GN, Auerbach JM (Eds). John Wiley & Sons, NJ, USA, 2-21 (2007).
40. Bosga-Bouwer AG, Hendriks D, Vellenga E, Zorgdrager H, van den Berg E. Cytogenetic analysis of cryopreserved bone marrow cells. Cancer Genet. Cytogenet. 124, 165-168 (2001). (Pubitemid 32112248)
41. Chauffaille MLLF, Pinheiro RF, Stefano JT, Kerbauy J. Karyotype of cryopreserved bone marrow cells. Braz. J. Med. Biol. Res. 36, 845-850 (2003). (Pubitemid 36939906)
42. Mitelman F, Johansson B, Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 7(4), 233-245 (2007). (Pubitemid 46480968)
43. Heng HH, Liu G, Bremer S, Ye KJ, Stevens J, Ye CJ. Clonal and non-clonal chromosome aberrations and genome variation and aberration. Genome 49, 195-204 (2006). (Pubitemid 43979153)
44. Vázquez-Mazariego Y, Ramiro S, Steegman JL, García-Sagredo JM, Sánchez-Hombre MC, Ferro MT. Nonclonal abnormalities in leukemia. Cancer Genet. Cytogenet. 118, 85-86 (2000).
45. Heim S, Mitelman F. Nonrandom chromosome abnormalities in cancer - an overview. In: Cancer Cytogenetics. Heim S, Mitelman F (Eds). Wiley-Blackwell, NJ, USA, 25-43 (2009).
46. Houghton J, Stoicov C, Nomura S et al. Gastric cancer originating from bone marrow-derived cells. Science 306, 1568-1571 (2004). (Pubitemid 39564955)
47. Riggi N, Cironi L, Provero P et al. Development of Ewings sarcoma from primary bone marrow-derived mesenchymal progenitor cells. Cancer Res. 65, 11459-11468 (2005). (Pubitemid 41821703)
48. Riggi N, Cironi L, Provero P et al. Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res. 66, 7016-7023 (2006). (Pubitemid 44197677)
49. Avital I, Moreira AL, Klimstra DS et al. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation. Stem Cells 25, 2903-2909 (2007). (Pubitemid 350127875)
50. Bonne A, Vreede L, Kuiper RP et al. Mapping of constitutional translocation breakpoints in renal cell cancer patients: identification of KCNIP4 as a candidate gene. Cancer Genet. Cytogenet. 179, 11-18 (2007). (Pubitemid 350018898)
51. Poland KS, Azim M, Folsom M et al. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma. Genes Chromosomes Cancer 46, 805-812 (2007). (Pubitemid 47106184)
52. Vandepoele K, Andries V, Van Roy N et al. A constitutional translocation t(1;17) (p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS One 3(5), E2207 (2008).
53. Yamamoto K, Okamura A, Kawano H, Katayama Y, Shimoyama M, Matsui T. A novel t(8;18)(q13;q21) in acute monocytic leukemia evolving from constitutional trisomy 8 mosaicism. Cancer Genet. Cytogenet. 176, 144-149 (2007). (Pubitemid 47081197)
54. Lefort N, Perrier AL, Laâbi Y, Varela C, Peschanski M. Human embryonic stem cells and genomic instability. Regen. Med. 4(6), 899-909 (2009).
55. Ross AL, Leder DE, Weiss J, Izakovic J, Grichnik JM. Genomic instability in cultured stem cells: associated risks and underlying mechanisms. Regen. Med. 6(5), 653-662 (2011).